Skip to content

Clinical trials

Phase 1 Gaucher Disease trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gaucher Disease Phase: Phase 1 Country / region: United States Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20111
20131
20141
20153
20181
20191
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi3
Genzyme, a Sanofi Company2
Amicus Therapeutics1
National Center for Research Resources (NCRR)1
National Institute of Mental Health (NIMH)1
National Institute of Neurological Disorders and Stroke (NINDS)1
New York Medical College1
Spur Therapeutics1
UNC Lineberger Comprehensive Cancer Center1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gaucher Disease14
Metabolism, Inborn Errors3
Mucopolysaccharidosis VI2
Wolman Disease2
Adrenoleukodystrophy1
Anemia, Aplastic1
Anemia, Diamond-Blackfan1
Fucosidosis1
Genetic Diseases, Inborn1
Leukemia, Myeloid, Acute1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.